Nadra J. Nilsen

Nadra J. Nilsen

Auto-generated profile, based on publicly available information

Nadra J. Nilsen

Norwegian University of Science and Technology, Institute of Cancer Research and Molecular Medicine, Olav Kyrres gt. 3, N-7489 Trondheim, Norway

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2004 in Nature Immunology
Verified
Journal Article
Open access
PDF file
ELEicke Latz
Eicke Latz
ASAnnett Schoenemeyer
Annett Schoenemeyer
AVAlberto Visintin
Alberto Visintin
KFKate Fitzgerald
Kate Fitzgerald
BMBrian G Monks
Brian G Monks
DGDouglas T Golenbock
Douglas T Golenbock
Microbial DNA sequences containing unmethylated CpG dinucleotides activate Toll-like receptor 9 (TLR9). We have found that TLR9 is localized to the endoplasmic reticulum (ER) of dendritic cells (DCs) and macrophages. Because there is no precedent for immune receptor signaling in the ER, we investigated how TLR9 is activated. We show that CpG DNA binds directly to TLR9 in ligand-binding studies. CpG DNA moves into early endosomes and is subsequently transported to a tubular lysosomal compartment. Concurrent with the movement of CpG DNA in cells, TLR9 redistributes from the ER to CpG DNA–containing structures, which also accumulate MyD88. Our data indicate a previously unknown mechanism of cellular activation involving the recruitment of TLR9 from the ER to sites of CpG DNA uptake, where signal transduction is initiated.

1 October 2010 in Immunity
Verified
Journal Article
Closed access
HHHarald Husebye
Harald Husebye
MAMarie Hjelmseth Aune
Marie Hjelmseth Aune
JSJørgen Stenvik
Jørgen Stenvik
ESEivind Samstad
Eivind Samstad
FSFrode Skjeldal
Frode Skjeldal
TETerje Espevik
Terje Espevik

5 May 2008 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
NNNadra J. Nilsen
Nadra J. Nilsen
SDSusanne Deininger
Susanne Deininger
UNUnni Nonstad
Unni Nonstad
FSFrode Skjeldal
Frode Skjeldal
HHHarald Husebye
Harald Husebye
TETerje Espevik
Terje Espevik
Lipoteichoic acid (LTA) is a central inducer of inflammatory responses caused by Gram-positive bacteria, such as Staphylococcus aureus, via activation of TLR2. Localization of TLR2 in relation to its coreceptors may be important for function. This study explores the signaling, uptake, and trafficking pattern of LTA in relation to expression of TLR2 and its coreceptors CD36 and CD14 in human monocytes. We found TLR2 expressed in early endosomes, late endosomes/lysosomes, and in Rab-11-positive compartments but not in the Golgi apparatus or endoplasmic reticulum (ER). Rapid internalization of fluorescently labeled LTA was observed in human monocytes, colocalizing with markers for early and late endosomes, lysosomes, ER, and Golgi network. Blocking CD14 and CD36 with antibodies inhibited LTA binding and LTA-induced TNF release from monocytes, emphasizing an important role for both molecules as coreceptors for TLR2. Importantly, blocking CD36 did not affect TNF release induced by N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)3-lysine or LPS. Expression of CD14 markedly enhanced LTA binding to the plasma membrane and also enhanced NF-κB activation. LTA internalization, but not NF-κB activation, was inhibited in Dynamin-I K44A dominant-negative transfectants, suggesting that LTA is internalized by receptor-mediated endocytosis but that internalization is not required for signaling. In fact, immobilizing LTA and thereby inhibiting internalization resulted in enhanced TNF release from monocytes. Our results suggest that LTA signaling preferentially occurs at the plasma membrane, is independent of internalization, and is facilitated by CD36 and CD14 as coreceptors for TLR2.

15 February 2005 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MMMaria Manukyan
Maria Manukyan
KTKathy Triantafilou
Kathy Triantafilou
MTMartha Triantafilou
Martha Triantafilou
Alan MackieAlan Mackie
Alan Mackie
NNNadra Nilsen
Nadra Nilsen
HHHolger Heine
Holger Heine
Lipoproteins or lipopeptides (LP) are bacterial cell wall components detected by the innate immune system. For LP, it has been shown that TLR2 is the essential receptor in cellular activation. However, molecular mechanisms of LP recognition are not yet clear. We used a FLAG‐labeled derivative of the synthetic lipopeptide N‐palmitoyl‐S‐[2,3‐bis(palmitoyloxy)‐(2R,S)‐propyl]‐(R)‐cysteinyl‐seryl‐(lysyl)3‐lysine (Pam3CSK4) to study the roles of CD14, TLR2 and TLR1 in binding and signaling of LP and their molecular interactions in human cells. The activity of Pam3CSK4‐FLAG was TLR2 dependent, whereas the binding was enabled by CD14, as evaluated by flow cytometry and confocal microscopy. Using FRET and FRAP imaging techniques to study molecular associations, we could show that after Pam3CSK4‐FLAG binding, CD14 and Pam3CSK4‐FLAG associate with TLR2 and TLR1, and TLR2 is targeted to a low‐mobility complex. Thus, LP binding to CD14 is the first step in the LP recognition, inducing physical proximity of CD14 and LP with TLR2/TLR1 and formation of the TLR2 signaling complex.

1 February 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NNNadra J. Nilsen
Nadra J. Nilsen
GVGregory I. Vladimer
Gregory I. Vladimer
JSJørgen Stenvik
Jørgen Stenvik
MOM. Pontus A. Orning
M. Pontus A. Orning
MZMaria V. Zeid-Kilani
Maria V. Zeid-Kilani
ELEgil Lien
Egil Lien
Toll-like receptors (TLRs) are involved in sensing invading microbes by host innate immunity. TLR2 recognizes bacterial lipoproteins/lipopeptides, and lipopolysaccharide activates TLR4. TLR2 and TLR4 signal via the Toll/interleukin-1 receptor adaptors MyD88 and MAL, leading to NF-κB activation. TLR4 also utilizes the adaptors TRAM and TRIF, resulting in activation of interferon regulatory factor (IRF) 3. Here, we report a new role for TRAM and TRIF in TLR2 regulation and signaling. Interestingly, we observed that TLR2-mediated induction of the chemokine Ccl5 was impaired in TRAM or TRIF deficient macrophages. Inhibition of endocytosis reduced Ccl5 release, and the data also suggested that TRAM and TLR2 co-localize in early endosomes, supporting the hypothesis that signaling may occur from an intracellular compartment. Ccl5 release following lipoprotein challenge additionally involved the kinase Tbk-1 and Irf3, as well as MyD88 and Irf1. Induction of Interferon-β and Ccl4 by lipoproteins was also partially impaired in cells lacking TRIF cells. Our results show a novel function of TRAM and TRIF in TLR2-mediated signal transduction, and the findings broaden our understanding of how Toll/interleukin-1 receptor adaptor proteins may participate in signaling downstream from TLR2. Background: Toll-like receptor 2 (TLR2) mediates innate immune responses by recognizing microbial components. Results: TLR2-mediated induction of the chemokines Ccl4 and Ccl5 and interferon-β is impaired in macrophages lacking the signaling molecules TRAM, TRIF, TBK-1, IRF1, and IRF3. Conclusion: The TRAM/TRIF pathway is involved in TLR2 signaling. Significance: TLR signaling pathways determine the immune response mounted against infectious organisms.

1 February 2013 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
AØAnn E. Østvik
Ann E. Østvik
AGAtle van Beelen Granlund
Atle van Beelen Granlund
MBMarit Bugge
Marit Bugge
NNNadra J. Nilsen
Nadra J. Nilsen
STSverre H. Torp
Sverre H. Torp
ASArne Kristian Sandvik
Arne Kristian Sandvik
Background. We explored the gene expression in colonic biopsies of active and inactive inflammatory bowel disease (IBD) in an extensive material of ulcerative